MAHA And GLP-1s Are About To Deal A Big Blow To The Processed-Foods Industrial Complex
MAHA And GLP-1s Are About To Deal A Big Blow To The Processed-Foods Industrial Complex The US processed-food industrial complex, partly controlled by globalist mega-corps, is beginning to reckon with...
Zero Hedge·3h ago
More News
Does Celsius Holdings' Buyback Plan Signal Stronger Growth Ahead?
CELH's $300 million buyback plan, supported by soaring revenues, rising margins and strong cash reserves, underscores its long-term confidence.
Zacks·11h ago
Guru Fundamental Report for PEP
Below is Validea's guru fundamental report for PEPSICO INC (PEP). Of the 22 guru strategies we follow, PEP rates highest using our P/B Growth Investor model based on the published strategy of Partha...
Nasdaq News: Markets·13h ago
PepsiCo, Inc. $PEP Shares Sold by Haverford Financial Services Inc.
Haverford Financial Services Inc. lowered its stake in PepsiCo, Inc. (NASDAQ:PEP - Free Report) by 10.8% in the second quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·14h ago
Heritage Wealth Advisors Sells 4,956 Shares of PepsiCo, Inc. $PEP
Heritage Wealth Advisors lessened its position in shares of PepsiCo, Inc. (NASDAQ:PEP - Free Report) by 1.7% during the second quarter, according to its most recent filing with the Securities and...
MarketBeat·15h ago
Alteri Wealth LLC Sells 2,933 Shares of PepsiCo, Inc. $PEP
Alteri Wealth LLC decreased its holdings in PepsiCo, Inc. (NASDAQ:PEP - Free Report) by 50.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission...
MarketBeat·19h ago
Rep. Scott DesJarlais Sells Off Shares of PepsiCo, Inc. (NASDAQ:PEP)
Representative Scott DesJarlais (R-Tennessee) recently sold shares of PepsiCo, Inc. (NASDAQ:PEP). In a filing disclosed on November 18th, the Representative disclosed that they had sold between...
PepsiCo's 2025 Playbook: Can Cost Cuts Fund an Innovation-Led Rebound?
PEP progresses with its 2025 strategy aimed at deep cost cuts and a stepped-up innovation push to rebuild margins and spark a healthier growth rebound.
Zacks·2d ago
Collegium Pharma and Entegris have been highlighted as Zacks Bull and Bear of the Day
COLL's momentum and value appeal contrast sharply with ENTG's slide on weak guidance and falling estimates, highlighting a split in market sentiment.